Back

Milk-derived extracellular vehicles alleviate heart failure with preserved ejection fraction by modulating gut microbiota

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Heart failure: new scientific insights (1) Heart Failure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Sitong Zhang

Singapore (Singapore)

7 More presentations in this session

Presentation thumbnail
Interleukin-22 inhibits right ventricular remodelling by a unique mechanism in a pulmonary artery constriction model.
Doctor K. Shibao (Kurume, JP)
Abstract Slides
Presentation thumbnail
CD14 blockade preserves left ventricular structure and systolic function in a murine model of ST-elevation myocardial infarction.
Doctor D. Donner (Melbourne, AU)
Abstract Slides
Presentation thumbnail
The STRIPAK associated kinase MST4 is a novel mediator in heart failure pathogenesis
Mr M. Leye (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
LCZ696 (sacubitril/valsartan) alleviates residual cardiac remodeling of large ventricular aneurysms after surgical ventricular reconstruction by mediating circMap4k2/LIN28A/PDK1 pathway
Ms J. Yan (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Daily Subcutaneous injections of Relaxin is a therapy for heart failure with preserved ejection fraction
Professor G. Salama (Pittsburgh, US)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: new scientific insights (1)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Exercise intensity prescription in heart failure patients: comparison of different physiological parameters
thumbnail
Congress Presentation
Award presentation
thumbnail
Congress Presentation
Spectrum of pericarditis from acute to burnt out

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources